Sumitomo Chemical India (SUMICHEM) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
16 Sep, 2026Executive summary
Revenue from operations declined to ₹28,325 million in FY 2023-24 from ₹35,110 million in FY 2022-23, reflecting a challenging year for the agrochemical sector due to erratic monsoons, lower demand, high-cost inventory, and declining prices.
Net profit after tax dropped to ₹3,697 million from ₹5,034 million year-over-year, with profit margins impacted by reduced sales and increased working capital requirements.
Despite headwinds, the company maintained strong financial discipline, continued investments in R&D, and launched nine new products in the last 18 months.
A special interim dividend of ₹5 per share was paid to commemorate the silver jubilee year, and a final dividend of ₹0.90 per share is proposed.
Financial highlights
EBITDA for FY 2023-24 was ₹474.6 million, with EBITDA margin at 16.7%, down from 18.4% in the previous year.
PAT margin decreased to 13.1% from 14.3% year-over-year.
Return on equity fell to 15.1% from 21.1% in FY 2022-23.
Domestic sales declined to ₹22,510 million (from ₹26,069 million), and exports to ₹5,553 million (from ₹8,664 million).
Inventory reduced significantly, supporting cash flows.
Outlook and guidance
The India Meteorological Department forecasts above-average monsoon for 2024, supporting a positive industry outlook.
The company plans to ramp up volumes from two new plants and expand manufacturing at the Dahej site.
Focus remains on new product launches, leveraging parent company’s proprietary molecules, and digital transformation to drive growth.
Latest events from Sumitomo Chemical India
- Q1FY27 profit and margins rose, driven by exports and an insurance claim despite sector headwinds.SUMICHEM
Q1 26/27 - Record profit, margin expansion, and a ₹1.30 dividend in FY26 amid regulatory risks.SUMICHEM
Q4 25/26 - 9MFY26 revenue rose 5% with margin gains, but Q3 saw profit drop from one-time Labour Code charge.SUMICHEM
Q3 25/26 - H1 FY26 delivered 9% revenue growth, robust cash flow, and new launches despite Q2 headwinds.SUMICHEM
Q2 25/26 - Q1FY25 saw strong revenue and profit growth, improved margins, and ongoing legal and seasonal risks.SUMICHEM
Q1 24/25 - Record H1 FY25 profit and margin growth driven by new products, exports, and strong demand outlook.SUMICHEM
Q2 24/25 - Q3FY25 saw robust revenue and profit growth, led by exports, with ongoing seasonal and regulatory risks.SUMICHEM
Q3 24/25 - Double-digit growth, record margins, and strong outlook, amid regulatory and climate risks.SUMICHEM
Q4 24/25 - Record Q1FY26 revenue and profit growth, with strong margins and ongoing regulatory risks.SUMICHEM
Q1 25/26